Abstract
Disordered cannabis use is linked to social problems, which could be explained by a subjective devaluation of nondrug social contexts and/or an overvaluation of cannabis-paired options relative to nondrug alternatives. To examine these hypotheses, measures to assess the subjective value of social- and/or cannabis-paired contexts were collected in people who use cannabis (n = 85) and controls (n = 98) using crowdsourcing methods. Measures included a cued concurrent choice task that presented two images (cannabis, social, social cannabis, and neutral images) paired with monetary options, hypothetical purchase tasks that included access to social parties with and without a cannabis “open bar,” and the Social Anhedonia Scale (SAS). Little evidence was found to suggest that the cannabis group undervalued social contexts. People who used cannabis demonstrated a preference for social- versus neutral-cued options, and no preference for cannabis- versus social cannabis-cued options on the choice task. In addition, social party demand and SAS scores did not differ between groups. In contrast, we observed evidence for an overvaluation of cannabis context in people who use cannabis, including preference for social cannabisversus social-cued options, and more disadvantageous choices for cannabis-cued options on the choice task, as well as more intense and inelastic demand for the social cannabis party compared to the social party. These results suggest that social problems associated with cannabis use could be at least partially explained by an overvaluation of cannabis-paired options, rather than devaluation of nondrug social-paired options, in the value calculations underlying drug use decisions.
| Original language | English |
|---|---|
| Pages (from-to) | 518-528 |
| Number of pages | 11 |
| Journal | Experimental and Clinical Psychopharmacology |
| Volume | 32 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2 2024 |
Bibliographical note
Publisher Copyright:© 2024 American Psychological Association
Funding
The authors gratefully acknowledge support from the National Institutes of Health, National Institute on Drug Abuse and National Center for Advancing Translational Sciences, Grant T32 DA035200 awarded to William W. Stoops, Grant R01 DA036550 awarded to Joshua A. Lile, Grants TL1 TR001997 and T32 DA07209, and pilot funding from the University of Kentucky. These funding agencies had no role in study design, data collection or analysis, and preparation and submission of the article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or University of Kentucky. The authors are grateful to the staff at the Laboratory of Human Behavioral Pharmacology as well as Lyndsey Armes and Catherine Bohnett for their contributions to this project. The authors have no conflicts of interest to disclose
| Funders | Funder number |
|---|---|
| National Institute on Drug Abuse | |
| National Institutes of Health (NIH) | |
| University of Kentucky | |
| National Center for Advancing Translational Sciences (NCATS) | TL1 TR001997, T32 DA07209, R01 DA036550, T32 DA035200 |
| National Center for Advancing Translational Sciences (NCATS) |
Keywords
- behavioral economic demand
- cannabis use disorder
- concurrent reinforcer choice
- value-based decision making
ASJC Scopus subject areas
- Pharmacology
- Psychiatry and Mental health
- Pharmacology (medical)